Untangling tau imaging

by Victor L. Villemagne, Nobuyuki Okamura, Christopher C. Rowe
Published 2016-01-01

Brain age in chronic traumatic brain injury

by Gershon Spitz, Amelia J. Hicks, Caroline Roberts, Christopher C. Rowe, Jennie Ponsford
Published 2022-01-01

Clinical profile of PiB-positive corticobasal syndrome.

by James R Burrell, Michael Hornberger, Victor L Villemagne, Christopher C Rowe, John R Hodges
Published 2013-01-01

Cerebral Microbleeds: A Review of Clinical, Genetic and Neuroimaging Associations

by Paul Andrew Yates, Paul Andrew Yates, Victor L Villemagne, Victor L Villemagne, Victor L Villemagne, Kathryn A Ellis, Kathryn A Ellis, Patricia M Desmond, Colin L Masters, Colin L Masters, Christopher C Rowe, Christopher C Rowe
Published 2014-01-01

Human biodistribution and internal dosimetry of 4-[ 18 F]fluorobenzyl-dexetimide: a PET radiopharmaceutical for imaging muscarinic acetylcholine receptors in the brain and heart

by Cameron D. Pain, Graeme J. O’Keefe, Uwe Ackermann, Vincent Dore, Victor L. Villemagne, Christopher C. Rowe
Published 2020-06-01

Inter‐scanner Aβ‐PET harmonization using barrel phantom spatial resolution matching

by Gihan P. Ruwanpathirana, Robert C. Williams, Colin L. Masters, Christopher C. Rowe, Leigh A. Johnston, Catherine E. Davey
Published 2024-01-01

Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease

by Georg M Kerbler, Jürgen Fripp, Christopher C Rowe, Victor L Villemagne, Olivier Salvado, Stephen Rose, Elizabeth J Coulson
Published 2015-01-01

Mapping the association between tau-PET and Aβ-amyloid-PET using deep learning

by Gihan P. Ruwanpathirana, Robert C. Williams, Colin L. Masters, Christopher C. Rowe, Leigh A. Johnston, Catherine E. Davey
Published 2022-08-01

Case Report: 18F-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player

by Natasha Krishnadas, Natasha Krishnadas, Vincent Doré, Vincent Doré, Fiona Lamb, Colin Groot, Paul McCrory, Rodney Guzman, Rachel Mulligan, Kun Huang, Meaghan O'Donnell, Meaghan O'Donnell, Jennie Ponsford, Malcolm Hopwood, Victor L. Villemagne, Christopher C. Rowe, Christopher C. Rowe
Published 2020-12-01

Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies

by Pierrick Bourgeat, Vincent Doré, James Doecke, David Ames, Colin L. Masters, Christopher C. Rowe, Jurgen Fripp, Victor L. Villemagne
Published 2021-02-01

Altered grey matter structural covariance in chronic moderate–severe traumatic brain injury

by Georgia F. Symons, Matthew C. Gregg, Amelia J. Hicks, Christopher C. Rowe, Sandy R. Shultz, Jennie L. Ponsford, Gershon Spitz
Published 2024-01-01

Avoiding methodological bias in studies of amyloid imaging results disclosure

by Carl Taswell, Cheryl Donohue, Maree T. Mastwyk, Andrea G. Louey, Jacqueline Giummarra, Joanne Robertson, David G. Darby, Colin L. Masters, Christopher C. Rowe
Published 2019-06-01

In vivo microstructural heterogeneity of white matter lesions in healthy elderly and Alzheimer's disease participants using tissue compositional analysis of diffusion MRI data

by Remika Mito, Thijs Dhollander, Ying Xia, David Raffelt, Olivier Salvado, Leonid Churilov, Christopher C. Rowe, Amy Brodtmann, Victor L. Villemagne, Alan Connelly
Published 2020-01-01

Evaluation of Cholinergic Deficiency in Preclinical Alzheimer’s Disease Using Pupillometry

by Shaun Frost, Liam Robinson, Christopher C. Rowe, David Ames, Colin L. Masters, Kevin Taddei, Stephanie R. Rainey-Smith, Ralph N. Martins, Yogesan Kanagasingam
Published 2017-01-01

Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET studyResearch in context

by Natasha Krishnadas, Vincent Doré, Joanne S. Robertson, Larry Ward, Christopher Fowler, Colin L. Masters, Pierrick Bourgeat, Jurgen Fripp, Victor L. Villemagne, Christopher C. Rowe
Published 2023-02-01

The protocol of a clinical quality registry for dementia and mild cognitive impairment (MCI): the Australian dementia network (ADNeT) Registry

by Xiaoping Lin, Kasey Wallis, Stephanie A. Ward, Henry Brodaty, Perminder S. Sachdev, Sharon L. Naismith, Karolina Krysinska, John McNeil, Christopher C. Rowe, Susannah Ahern
Published 2020-09-01

Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods

by Mark R. Battle, Lovena Chedumbarum Pillay, Val J. Lowe, David Knopman, Bradley Kemp, Christopher C. Rowe, Vincent Doré, Victor L. Villemagne, Christopher J. Buckley
Published 2018-12-01

Evaluation of GammaH2AX in Buccal Cells as a Molecular Biomarker of DNA Damage in Alzheimer’s Disease in the AIBL Study of Ageing

by Mohammad Sabbir Siddiqui, Maxime Francois, Stephanie Rainey-Smith, Ralph Martins, Colin L. Masters, David Ames, Christopher C. Rowe, Lance S. Macaulay, Michael F. Fenech, Wayne R. Leifert
Published 2020-08-01

Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study

by Vincent Dore, Christopher C Rowe, Meinir Krishnasamy, Haryana Dhillon, Adam K Walker, Karla Gough, Priscilla Gates, Carlene Wilson, Eliza Hawkes, Yuliya Perchyonok, Janette L Vardy, Michiel de Ruiter
Published 2020-09-01

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and L...

by Samantha L. Gardener, Samantha L. Gardener, Stephanie R. Rainey-Smith, Stephanie R. Rainey-Smith, Stephanie R. Rainey-Smith, Stephanie R. Rainey-Smith, Victor L. Villemagne, Jurgen Fripp, Vincent Doré, Vincent Doré, Pierrick Bourgeat, Kevin Taddei, Kevin Taddei, Christopher Fowler, Colin L. Masters, Paul Maruff, Paul Maruff, Christopher C. Rowe, Christopher C. Rowe, David Ames, David Ames, Ralph N. Martins, Ralph N. Martins, Ralph N. Martins, the AIBL Investigators
Published 2021-11-01